Esri Tablet

Adult dose

This medication should be taken as follows: take 24 pink active tablets daily for 24 days, and then take the white or whitish placebo tablets for 4 days. You can start on day 1 of your menstrual cycle or on the first Sunday after the start of your menstrual cycle. It is advisable to take it at the same time each day, preferably after dinner or before bed, and it can be taken regardless of meals. When starting for the first time, if you have not used hormonal contraception last month, begin with the first dose.

This medication can significantly increase the risk of serious cardiovascular side effects, particularly thrombosis, in women who smoke. Women over 35 years of age should particularly avoid using this medication while smoking, as the risk is further heightened. Women over 35 who smoke more than 15 cigarettes a day should not take this medication. The drospirenone component in this medication can cause hyperkalemia, which is the elevation of potassium levels in the blood. Patients with renal, hepatic, or adrenal dysfunction should not take this medication, and if they are taking other medications that may elevate potassium levels in the blood, potassium levels should be monitored closely upon the first dose. This medication is only to be used by women aged 14 and older who have no issues taking oral contraceptives, and should not be used before menarche. Additionally, it should only be taken for birth control purposes. If there are any signs of cardiovascular issues or thrombotic symptoms, this medication should be immediately discontinued. It should not be taken during the 4 weeks prior to surgery and for 2 weeks following surgery. Women who do not breastfeed after childbirth are advised not to start this medication within 4 weeks postpartum. This medication carries risks related to thrombosis, such as venous or arterial thromboembolism, and should not be used in patients with a history of thrombosis, myocardial infarction, stroke, or other conditions with high thrombotic risk. Patients with severely impaired liver function, severe hypertension, those who are pregnant or of childbearing potential, and nursing mothers should also avoid this medication. This medication contains lactose, therefore patients with lactose intolerance or genetic metabolic disorders should not take it. While taking this medication, regular monitoring of blood pressure and breast and uterine conditions is necessary, and if there's a family history of thrombosis, testing for thrombotic risk factors is required. There may be a slight increase in the risk of breast cancer, cervical cancer, and other risks associated with the use of oral contraceptives, therefore regular check-ups are important. While taking this medication, side effects such as nausea, vomiting, bleeding, headache, breast pain, weight changes, and mood changes may occur, and if symptoms of thrombosis or severe migraines occur, it is essential to consult medical personnel immediately. This medication may interact with other drugs, so you must inform your healthcare provider if you are taking other medications. Before and during the use of this medication, individuals should carefully assess their health condition and risk factors to weigh the benefits and risks of this medication.

Serious side effects

Urticaria, angioedema, severe reactions accompanied by respiratory and circulatory symptoms (including anaphylaxis/anaphylactic-like reactions), venous thrombosis, arterial or venous thromboembolism, pulmonary embolism, myocardial infarction, cerebral hemorrhage, cerebral thrombosis, hypertension, gallbladder disease, hepatic adenoma and benign liver tumors, mesenteric thrombosis, retinal thrombosis, jaundice, mental confusion, severe edema accompanied by increased blood pressure, hematuria, increased tendency for thrombosis

Mild side effects

Nausea, vomiting, gastrointestinal symptoms (upper abdominal cramps and bloating), persistent bleeding, spotting, changes in menstrual cycle, amenorrhea, temporary infertility after discontinuation, edema, persistent melasma, breast changes (breast pain, enlargement, milk secretion, breast tenderness, breast discharge), weight changes (increase or decrease), changes in the uterus, decreased milk production shortly after delivery, migraine, rash (allergic), mental depression, decreased glucose tolerance, vaginal candidiasis

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. Storing in this manner will help maintain the medication's effectiveness for a longer period.

Appearance

Placebo tablet - white or whitish-colored, biconvex, round film-coated tablet Active tablet - pink, biconvex, round film-coated tablet

Package unit

28 tablets/box [(28 tablets/PTP)]